TABLE 4.

Three-year survival rates in different subgroups defined by the integration of combined immunoscore with Tumor, Node, Metastasis (TNM) stage classification: On the first column, 3-year survival rates according to stages I, II, and III are reported.

3-year survival rate (%)	Combined immunoscore (PT CD8+, CD4+, CD68+)
pStage	Low 86%	High 59%
II 77%	86%	78%
IIIA 64%	93%	48%
IIIB 43%	0%	38%

In the second and third columns, 3-year survival rates of low and high peritumoral (PT) combined immunoscore within each stage are reported. In bold, statistically significant different values are reported. Low PT combined immunoscore stage IIIB was present in one patient.